2025 is going to be a big year for AI adoption in pharma. By now, most life science companies have at least experimented with one generative AI (GenAI) pilot; according to a 2024 report from Bain, 60% ...
When analytics leaders can point to documented cost savings, time reduction and revenue impact in real time, the debate over AI investment shifts from assumption to measurable value. As recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback